Wanbury showcased its brand strength when two of its brands Cpink Total and Coriminic won prestigious AWACS Awards for marketing excellence.
Cpink Total Won “New introduction of the year” 2015-16 Gold award, and Coriminic won the 1st runner up award in the category “Brand of the Year” 2015-16.
Cpink total launched in 2015 is an innovative solution to treat anemia and associated complications in high risk pregnancy. The product formulated to improve patient compliance by offering sustained release ferrous ascorbate along with essential vitamins and minerals, is gaining wide acceptance amongst gynecologists.
Coriminic is the 2nd largest brand of Wanbury. Clocking a sale of 25 crores in 2015-16, Coriminic has shown a consistent growth over last 3 years with a CAGR of 23%. The brand has a very high equity amongst pediatricians.
Vice chairman of Wanbury Limited, K Chandran said, “We are delighted that two of our products have been awarded for being best brands in the market. This recognition is an acknowledgement of the commitment of our teams and the acceptance of our products by customers. This will motivate us to enhance our performance and do better in the coming years.”
AWACS is a market research agency with syndicated audit Pharma Trac. Every year, AWACS Awards in Marketing Excellence recognizes and awards the top performers from the domestic pharmaceutical industry. Broadly, there were two categories namely Brand of the Year and New Introduction- both divided into sub-categories of acute, chronic and sub chronic.
Wanbury Limited, one of India’s fastest growing pharmaceutical companies in India has a strong presence in API global market and domestic branded Formulation. Wanbury’s major thrust area lies in Active Pharmaceutical Ingredient (API) sale in over 70 countries and Pan-India Formulation presence.
Wanbury has a strong presence amongst gynecologists, orthopedicians pediatricians and physicans in domestic formulations. Wanbury offers unique & innovative products like Folinine, Rabiplus Adtrol plus and Chymonac to name a few.